Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose ACH-0137171 in chronic hepatitis C
2006-002696-40Phase 2Terminated
- Sponsor
- Achillion Pharmaceuticals
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hepatitis C virus infection comparing ACH-0137171 multiple-dose arm with Placebo arm (2 arms). Primary endpoints: Safety, Tolerability and 2 more. Started Jan 2007; status: terminated.
02
Drugs
ACH-0137171
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2006-002696-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002696-40.